share_log

四川百利天恒药业股份有限公司2024年度“提质增效重回报”行动方案的半年度评估报告

Mid-year evaluation report of the "Quality Improvement and Efficiency Return" action plan for Sichuan Baili Tianheng Pharmaceutical Co., Ltd. in 2024

SZSI ·  Aug 23
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more